27-Mar-2020 | Facts and Factors
Findings from Facts and Factors report “HLA Typing for Transplant Market By Technology (Non-Molecular Assays and Molecular Assays), By Product and Services (Instruments, Reagents and Consumables, Software, and Services), By Application (Diagnostics and Research), By End-Use (Hospitals and Transplant Centers, Commercial Service Providers, Academic Institutes and Research Laboratories), and By Region: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” states that the global HLA Typing for Transplant market in 2019 was approximately USD 664.6 Million. The market is expected to grow at a CAGR of 7.5% and is anticipated to reach around USD 1102.6 Million by 2026.
HLA typing is used to recognize the HLA antigens group present in an individual. The identification of HLA-class I and class II antigens helps provide accurate testing results for further compatibility purposes in case of organ transplantation. The HLA typing tests are carried out using advanced DNA innovations.
Browse the full “HLA Typing for Transplant Market By Technology (Non-Molecular Assays and Molecular Assays), By Product and Services (Instruments, Reagents and Consumables, Software, and Services), By Application (Diagnostics and Research), By End-Use (Hospitals and Transplant Centers, Commercial Service Providers, Academic Institutes and Research Laboratories), and By Region: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026" https://www.fnfresearch.com/global-hla-typing-for-transplant-market-by-technology-962
Market Drivers:
The increasing requirement for organ donors coupled with the increasing number of transplants across the globe is projected to surge the global HLA Typing for Transplant market growth. Furthermore, the increasing number of heart, kidney, liver, lung, cancer, etc. disorders across the world is fueling market expansion. The growing geriatric population increases the instances of organ transplantation. This factor is majorly estimated to drive the market during the forecast period. Moreover, the technological advancements and the huge gap between the organ donation supply and demand chain are impeding the market expansion. The growing awareness about organ donation owing to the government and private organizations’ efforts will boost sales during the forecast timeframe. The growing healthcare infrastructure, high funding, and research grants also augment market demand. However, the expensive molecular HLA typing techniques are estimated to restrain market growth.
Market Segment Dominance:
- Molecular assays category exhibits a fastest-growth rate
Molecular assays category is likely to grow at a faster rate during the forecast period owing to the increasing applications of the HLA typing techniques. The faster and precise results provided by the molecular methods over non-molecular methods are anticipated to accelerate the HLA Typing for Transplant market growth. Furthermore, the launch of next-generation sequencing will further surge the application of molecular methods.
- Services category exhibits the highest growth in the global HLA Typing for Transplant market
Services category is anticipated to grow at a lucrative rate owing to the high trend of subcontracting HLA typing to intermediary firms. In addition to this, resource unavailability and cost-effectiveness will boost market growth.
- Diagnostics category is projected to lead the market during the forecast period
The HLA typing is majorly used in the diagnostics sector owing to the high demand for the technique for checking the compatibility of tissue and organ transplant recipients with donors. The increasing cases of transplantations and organ donations will fuel market growth. The advancing research will further provide new opportunities for the diagnostic category.
- Hospitals and transplant centers category is anticipated to dominate the global HLA Typing for Transplant market
Hospitals and transplant centers are anticipated to lead the market due to the presence of skilled medical professionals and innovative technologies. Furthermore, the growing number of patients needing transplants in hospitals is predicted to augment demand.
Regional Dominance:
- North America will dominate the global HLA Typing for Transplant market
North America HLA Typing for Transplant market is expected to be booming owing to the increasing demand for an organ transplant, high survival rate, and spurring geriatric population in the region. Additionally, the successful approval of HLA products by the regulatory bodies increases the availability of these products in this region, thereby fostering the market growth. The high prevalence of targeted diseases such as heart failure, cancer, renal diseases, etc. in the U.S. and Canada coupled with the technological advancements in the HLA-based transplant diagnostics field is anticipated to boost the growth of the global HLA Typing for transplant market.
Report Scope
Report Attribute |
Details |
Market Size in 2019 |
USD 664.6 Million |
Projected Market Size in 2026 |
USD 1102.6 Million |
CAGR Growth Rate |
7.5% CAGR |
Base Year |
2019 |
Forecast Years |
2020–2026 |
Key Market Players |
Pacific Biosciences of California Incorporation, GenDx, Bio-Rad Laboratories, Abbott Laboratories, CareDx, Inc., Omixon, Inc., Bio-Reference Laboratories, Linkage Biosciences (Thermo Fischer Scientific), F. Hoffmann-La Roche, Ltd., Immucor, Inc., Luminex Corporation, Illumina, Inc., and Inno-train Diagnostik GmbH, and Qiagen. |
Key Segment |
By Technology, By Products, By Application, By End-User, and By Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Key Market Players:
Some of the key players in the global HLA Typing for Transplant market include Pacific Biosciences of California Incorporation, GenDx, Bio-Rad Laboratories, Abbott Laboratories, CareDx, Inc., Omixon, Inc., Bio-Reference Laboratories, Linkage Biosciences (Thermo Fischer Scientific), F. Hoffmann-La Roche, Ltd., Immucor, Inc., Luminex Corporation, Illumina, Inc., and Inno-train Diagnostik GmbH, and Qiagen.
This report segments the global HLA Typing for Transplant market as follows:
Global HLA Typing for Transplant Market: Technology Segmentation Analysis
- Serological Assay
- Mixed Lymphocyte Culture Assay
- Sequence specific primer-PCR
- Sequence specific oligonucleotide-PCR
- Next Generation Sequencing
- Sanger’s Sequencing
Global HLA Typing for Transplant Market: Products and Services Segmentation Analysis
- Instruments
- Reagents and Consumables
- Software and Services
Global HLA Typing for Transplant Market: Application Segmentation Analysis
Global HLA Typing for Transplant Market: End-User Segmentation Analysis
- Hospitals and Transplant Centers
- Research Laboratories and Academic Institutions
- Commercial Service Providers
Global Market: Regional Segmentation Analysis
- North America
- Europe
- Germany
- The UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
Global Headquarters
Level 8, International Finance Center, Tower 2,
8 Century Avenue, Shanghai,
Postal - 200120, China
Tel: +86 21 80360450
Email: [email protected]
Web: https://www.fnfresearch.com
